Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Product › Details

ASCO Annual Meeting

Products Next higher product group conference, medicine/diagnostics
Organisation Organisation American Society of Clinical Oncology (ASCO)
     

Medigene AG. (5/18/15). "Press Release: Medigene to Participate in Investment and Scientific Conferences". Martinsried.

Medigene AG (MDG1, Frankfurt, Prime Standard) announces its participation in three upcoming investment and scientific conferences:


BioEquity Europe - The 16th Collaborative Gathering of Corporate & Investment Communities for the European Life Science

Date: 19 - 20 May 2015
Location: Vienna, Austria
Company presentation: 19 May 4.40 pm local time
Speaker: Peter Llewellyn-Davies, CFO Medigene AG
.

Conférence du LICR, Ludwig Center for Cancer Research of the University of Lausanne

Date: 21 May 2015
Location: Lausanne, Switzerland
Speaker: Dolores J. Schendel, CSO Medigene AG


ASCO, American Society of Clinical Oncology Annual Meeting 2015

Date: 29 May - 02 June 2015
Location: Chicago, USA


Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies. Medigene is the first German biotech company to have revenues from a marketed product, which is distributed by commercial partner companies. Medigene has advanced drug candidates which are licensed to partners and additional candidates in clinical development. The company is developing highly innovative treatment platforms concentrating on cancer and autoimmune diseases. For more information, please visit www.medigene.com.


This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® EndoTAG® and Veregen® are registered trademarks of Medigene AG. These trademarks may be owned or licensed in select locations only.


Contact Medigene

Julia Hofmann, Anja Clausnitzer
Tel.: +49 - 89 - 20 00 33 - 33 01
Email: investor@medigene.com

   
Record changed: 2018-05-13

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px
» Show all Events!


ASCO Annual Meeting

Past & forthcoming events


To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our free web portals Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px




» top